Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.

Kanazawa T, Glatt SJ, Kia-Keating B, Yoneda H, Tsuang MT. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder. Psychiatric Genetics. 2007;17(3):165-70. DOI: 10.1097/YPG.0b013e32801da2e2. PubMed PMID: 17417060.

Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.

Kheirollahi M, Kazemi E, Ashouri S. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies. Cell Mol Neurobiol. 2016;36(1):1-10. DOI: 10.1007/s10571-015-0229-z. PubMed PMID: 26134309.

The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: an updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls.

Zhao X, Huang Y, Chen K, Li D, Han C, Kan Q. The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: an updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls. Psychiatry Res. 2015;225(1-2):217-20. DOI: 10.1016/j.psychres.2014.11.015. PubMed PMID: 25468641.

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

Numata S, Ueno S-I, Iga J-ichi, Yamauchi K, Hongwei S, Ohta K, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci Lett. 2006;401(1-2):1-5. DOI: 10.1016/j.neulet.2006.02.054. PubMed PMID: 16533563.

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.

Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci. 2006;60(1):70-6. DOI: 10.1111/j.1440-1819.2006.01462.x. PubMed PMID: 16472361.

Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.

Zhang XY, Chen DC, Xiu MH, Haile CN, Luo X, Xu K, et al. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. Hum Genet. 2012;131(7):1187-95. DOI: 10.1007/s00439-012-1150-x. PubMed PMID: 22362486; PubMed Central PMCID: PMC3671849.

Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.

Lu W, Zhang C, Yi Z, Li Z, Wu Z, Fang YR. Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia. J Mol Neurosci. 2012;47(3):505-10. DOI: 10.1007/s12031-012-9750-4. PubMed PMID: 22477643.

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia.

Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2003;8(6):592-610. DOI: 10.1038/sj.mp.4001308. PubMed PMID: 12851636.

Neurotrophic factors and the pathophysiology of schizophrenic psychoses.

Durany N, Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. European Psychiatry. 2004;19(6):326-37. DOI: 10.1016/j.eurpsy.2004.06.020. PubMed PMID: 15363470.

Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.

Lee B-H, Kim Y-K. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology. 2009;59(1):51-8. DOI: 10.1159/000205518. PubMed PMID: 19270464.